LPIN1 and acute myeloid leukemia: Within the intermediate risk group, LPIN1 had the highest expression levels in AML with co‐mutations in NPM1, FLT3, and DNMT3A, which we had previously reported to possess high LSC frequencies and to be associated with poor outcomes (Figure S1A).32